[1] Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer [J]. Science, 1994, 266(352): 2011-4. [2] Shay JW, Zou Y, Hiyama E, et al. Telomerase and cancer[J]. Hum Mol Genet, 2001, 10(7): 677-85. [3] Shay JW, Werbin H, Wright WE. Telomere and telomerase in human leukemia[J]. Leukemia, 1996, 10(23): 1255-61. [4] Kirkpatrick KL, Mokbel K. The significance ofhman telomerase reverse transcriptase (hTERT) in cancer[J]. Eur J Surg Oncol, 2001,27(8): 754-60. [5] 孙来保,李成荣,文剑明,等.正、反义hTERT基因真核表达载体的构建与鉴定[J].第一军医大学学报,2003,23(9):899-902.Sun LB, Li CR, Wen MJ, et al. Construction and identification of eukaryotic expression vector for sense and anfisense human telomerase reverse transcriptase [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(9): 899-902. [6] Teixeira LA, Fricke CH, Bonorino CB, et al. An efficient gene transfer system for hematopoietic cell line using transient and stable vectors[J]. J Biotechnol, 2001, 88(2): 159-65. [7] Emrich T, Karl G, Panzinger B. Detection oftelomerase components by quantitative real-time on-line PCR analysis with the LightCycler [J]. Biochemiea, 2000, 4(1): 16-9. [8] 孙来保,文剑明,张萌,等.侵袭性骨肿瘤端粒酶活性检测及其意义[J].中华骨科杂志,1998,18(10):615-8.Sun LB, Wen JM, Zhang M, et al. Telomerase activity in aggressive bone rumors and its significance[J]. Chin J Orthop, 1998, 18(10):615-8. [9] 程宝鸾.动物细胞培养技术[M].广州:华南理工大学出版社,2001. 124-32. [10] White LK, Wright WE, Shay JW. Telomerase inhibitors[J]. Trends Biotechnol, 2001, 19(3): 114-20. |